Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
- PDF / 1,230,646 Bytes
- 3 Pages / 595.276 x 790.866 pts Page_size
- 79 Downloads / 197 Views
(2020) 39:167
CORRECTION
Open Access
Correction to: Musashi2 promotes EGFinduced EMT in pancreatic cancer via ZEB1ERK/MAPK signaling Weiwei Sheng1†, Xiaoyang Shi1†, Yiheng Lin1, Jingtong Tang1, Chao Jia1, Rongxian Cao2, Jian Sun1, Guosen Wang3, Lei Zhou4 and Ming Dong1* Correction to: J Exp Clin Cancer Res 39, 16 (2020) https://doi.org/10.1186/s13046-020-1521-4 Following publication of the original article [1], the authors identified some minor errors in image-typesetting in Figs. 2 and 3; specifically in Fig. 2a, and Fig. 3b and Fig. 3d (corrected labels beneath the quantitative histograms). The correct figure is given below. All correction had no any effect to the final conclusion. Author details 1 Department of Gastrointestinal Surgery, the First Hospital, China Medical University, Shenyang 110001, China. 2Department of General Surgery, the People’s Hospital of Liaoning province, Shenyang 110034, China. 3 Department of General Surgery, the First Hospital of Nanchang University, NanChang 330006, China. 4Department of General Surgery, the Central Hospital of JingZhou City, JingZhou 434020, China.
Reference 1. Sheng W, et al. Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. J Exp Clin Cancer Res. 2020;39:16. https://doi. org/10.1186/s13046-020-1521-4.
The original article can be found online at https://doi.org/10.1186/s13046020-1521-4. * Correspondence: [email protected] † Weiwei Sheng and Xiaoyang Shi contributed equally to this work. 1 Department of Gastrointestinal Surgery, the First Hospital, China Medical University, Shenyang 110001, China Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Sheng et al. Journal of Experimental & Clinical Cancer Research
(2020) 39:167
Page 2 of 3
Fig. 2 Cell morphology in sg1-MSI2, sg2-MSI2 and scramble transfected AsPC-1 and BxPC-3 cells with or without EGF (50 ng/ml) treatment. a and b Under EGF treatment, the fibroblastoid-like phenotype in AsPC-1
Data Loading...
